Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kragie BioMedWorks is a specialized life sciences consulting firm that provides strategic regulatory, clinical, and medical writing services to biotechnology and pharmaceutical companies. The firm assists clients in navigating the complex FDA and international regulatory landscapes, from early-stage development through post-marketing requirements. Led by Dr. Barbara Kragie, the company leverages deep expertise in clinical trial design, IND/NDA submissions, and safety reporting. Their services are designed to accelerate the development of novel therapeutics by ensuring high-quality data presentation and regulatory compliance. The consultancy often acts as an extension of a client's internal regulatory team, providing both high-level strategic oversight and hands-on document preparation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kragie BioMedWorks.